MedTrace Logo

Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)

NCT03349242 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2024-06-20

No results posted yet for this study

Summary

The rod-cone dystrophies (often referred to as retinitis pigmentosa (RP)) are a clinically and genetically heterogeneous group of disorders in which there is progressive loss of rod and later cone photoreceptor function leading to severe visual impairment. RP usually occurs as an isolated retinal disorder, but it may also be seen in association with systemic abnormalities.

Conditions

Sponsors & Collaborators

  • Janssen, LP

    collaborator INDUSTRY

  • MeiraGTx UK II Ltd

    lead INDUSTRY

Principal Investigators

  • Michel Michaelides, Prof · UCL/Moorfields

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-19
Primary Completion
2024-04-19
Completion
2024-04-19

Countries

  • United States
  • Canada
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03349242 on ClinicalTrials.gov